170 related articles for article (PubMed ID: 18203843)
21. CB2 receptor-mediated migration of immune cells: it can go either way.
Miller AM; Stella N
Br J Pharmacol; 2008 Jan; 153(2):299-308. PubMed ID: 17982478
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
23. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
24. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
Sterin-Borda L; Del Zar CF; Borda E
Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
[TBL] [Abstract][Full Text] [Related]
25. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
[TBL] [Abstract][Full Text] [Related]
26. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Ruhl T; Karthaus N; Kim BS; Beier JP
Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
[TBL] [Abstract][Full Text] [Related]
27. Presence of functional cannabinoid receptors in human endocrine pancreas.
Bermúdez-Silva FJ; Suárez J; Baixeras E; Cobo N; Bautista D; Cuesta-Muñoz AL; Fuentes E; Juan-Pico P; Castro MJ; Milman G; Mechoulam R; Nadal A; Rodríguez de Fonseca F
Diabetologia; 2008 Mar; 51(3):476-87. PubMed ID: 18092149
[TBL] [Abstract][Full Text] [Related]
28. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.
Han KH; Lim S; Ryu J; Lee CW; Kim Y; Kang JH; Kang SS; Ahn YK; Park CS; Kim JJ
Cardiovasc Res; 2009 Dec; 84(3):378-86. PubMed ID: 19596672
[TBL] [Abstract][Full Text] [Related]
29. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.
Montecucco F; Burger F; Mach F; Steffens S
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1145-55. PubMed ID: 18178718
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of allergic contact dermatitis through the endocannabinoid system.
Karsak M; Gaffal E; Date R; Wang-Eckhardt L; Rehnelt J; Petrosino S; Starowicz K; Steuder R; Schlicker E; Cravatt B; Mechoulam R; Buettner R; Werner S; Di Marzo V; Tüting T; Zimmer A
Science; 2007 Jun; 316(5830):1494-7. PubMed ID: 17556587
[TBL] [Abstract][Full Text] [Related]
32. Anandamide receptor signal transduction.
Goodfellow CE; Glass M
Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
34. Update on the role of cannabinoid receptors after ischemic stroke.
Capettini LS; Savergnini SQ; da Silva RF; Stergiopulos N; Santos RA; Mach F; Montecucco F
Mediators Inflamm; 2012; 2012():824093. PubMed ID: 22577257
[TBL] [Abstract][Full Text] [Related]
35. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils.
Oka S; Ikeda S; Kishimoto S; Gokoh M; Yanagimoto S; Waku K; Sugiura T
J Leukoc Biol; 2004 Nov; 76(5):1002-9. PubMed ID: 15316028
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid receptors and endocannabinoids: evidence for new players.
Mackie K; Stella N
AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
[TBL] [Abstract][Full Text] [Related]
37. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.
Fakhoury M
Mol Neurobiol; 2017 Jan; 54(1):768-778. PubMed ID: 26768595
[TBL] [Abstract][Full Text] [Related]
38. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
39. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
40. Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the Fructose-Fed Rats.
Chen IH; Cheng JT; Tong YC
Low Urin Tract Symptoms; 2018 May; 10(2):198-203. PubMed ID: 28386998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
